Jim Simons Caribou Biosciences, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRBU
# of Institutions
134Shares Held
43.6MCall Options Held
25KPut Options Held
53.2K-
Black Rock Inc. New York, NY6.95MShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$7.32 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.07MShares$5.49 Million0.46% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.27MShares$4.07 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$3.24 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $109M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...